A study led by Shoukhrat Mitalipov at Oregon Health and Science University is using CRISPR gene-editing technology to alter the DNA of embryos. The objective of the experiments is a process called "germline engineering" as a means to correct or eradicate genes that are the source of inherited diseases such as beta-thalassemia.
US scientists study gene editing in human embryos using CRISPR
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.